Clinical Trials Logo

Pediatric clinical trials

View clinical trials related to Pediatric.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06146452 Active, not recruiting - Palliative Care Clinical Trials

Micronutrient Status in Pediatric Palliative Care

Start date: October 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to determine the micronutrient levels in patients in the Pediatric Palliative Care Clinic. The main question it aims to answer are: • What is the frequency of micronutrient deficiencies in pediatric palliative care patients?

NCT ID: NCT06031831 Active, not recruiting - Clinical trials for Congenital Heart Disease

Analysis of Risk Factors and Prognosis of Pediatric Patients After Operations for Congenital Heart Disease

Start date: May 15, 2022
Phase:
Study type: Observational [Patient Registry]

This hospital-based retrospective study reviewed patients who underwent surgery for CHD between 2017 and 2020 and analyzed the clinical features and outcomes associated with airway anomalies.

NCT ID: NCT05900180 Active, not recruiting - Pediatric Clinical Trials

Pediatric Speech Therapy Session Frequency and Speech Outcomes

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare speech therapy outcomes in children ages 18 months to 16 years who participate in weekly speech therapy with home programming versus every-other week speech therapy with home programming in outpatient speech therapy. The main question it aims to answer is: Does a change in how often speech therapy sessions are delivered show an increased benefit in language and articulation standardized test scores? Participants will be randomly assigned to either (1) weekly or (2) every-other-week speech therapy for a total of 8 sessions. Researchers will compare these two groups to see if there are differences in speech outcomes.

NCT ID: NCT05453968 Active, not recruiting - Pediatric Clinical Trials

Berotralstat Treatment in Children With Hereditary Angioedema

APeX-P
Start date: October 25, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics (PK) and safety of berotralstat to determine the appropriate weight-based dose for pediatric participants 2 to < 12 years old for prophylactic treatment to prevent attacks of hereditary angioedema (HAE).

NCT ID: NCT04472286 Active, not recruiting - Lymphoma Clinical Trials

Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors

HBHL
Start date: November 1, 2020
Phase:
Study type: Observational

This project will examine habitual physical activity, bone health, and insulin resistance in pediatric acute lymphocytic leukemia (ALL) and lymphoma cancer survivors at two time points: baseline and 6 months. At the two study timepoints, all study participants will be asked to wear an accelerometer, receive a DXA scan of the lumbar spine and hip, and have blood drawn for analysis. Study participants will be given a gift card stipend for each study visit attended. Study visits will coincide with regular office visits to Children's Hospital Oncology Clinic and the Children's Hospital Survivorship Clinics whenever possible. The potential mechanism by which physical activity mediates bone changes will be explored by concurrently measuring changes in lean/fat mass and metabolic status. This pilot study will provide data to inform the design of a randomized controlled trial to test the effect of a physical activity intervention on bone health in PCS.

NCT ID: NCT04176640 Active, not recruiting - Pediatric Clinical Trials

Quantifying Brain Injury on Computed Tomography in Hospitalized Children

QBIct
Start date: October 20, 2015
Phase:
Study type: Observational

Lay Summary: To evaluate a novel early diagnostic tool for hospitalized children with traumatic brain injury. The Problem: Children who present with decreased level of consciousness after injury require urgent medical attention determined by the type and the severity of injury. Unfortunately, history and physical findings are often unreliable in the first hours after hospitalization, the period in which urgent management decisions must be made for their treatment. The Solution: A promising tool developed for measuring detectable evidence of traumatic brain injury on routine brain scans. The tool combines features invisible to the human eye but detectable by computer software with expert knowledge.This study will evaluate how well the tool can perform in a real health care setting. It is believed that it will greatly improve the efficacy and quality of care provided to children after traumatic brain injury.

NCT ID: NCT02545712 Active, not recruiting - Pediatric Clinical Trials

Safe Excipient Exposure in Neonates and Small ChildreN

SEEN
Start date: January 2016
Phase: N/A
Study type: Observational

The purpose of this study is to explore the quantity of excipient exposure in neonatal and young pediatric patients in a Danish Hospital. The focus will be on the preservatives ethanol, propyl glycol, benzyl alcohol, methyl-p-hydroxybenzoate and propanyl-p-hydroxybenzoate and the artificial sweeteners acesulfam potassium, aspartame, glycerol and sorbitol.